You are here

Drug developer Cennerv makes second bid to list on Catalist


SINGAPORE-based biotech Cennerv Pharmaceuticals is making a second attempt at an initial public offering (IPO) on the Singapore Exchange's Catalist board, with the lodging of another preliminary offer document on Wednesday. Details of the pricing, amount to be raised, and timing...

Market voices on: